Report : North America Diet Pills Market Forecast to 2028 –Regional Analysis – By Product Type (Prescription, Over the Counter Drugs, and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Children and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)
Prescription Segment to Dominate North America Diet Pills Market During 2021–2028
According to a new market research study on “North America Diet Pills Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product Type, Application, Age Group, Distribution Channel, and Country” is expected to reach US$ 949.03 million by 2028 from US$ 466.95 million in 2021. The market is estimated to grow at a CAGR of 10.7% from 2021 to 2028. The report provides trends prevailing in the North America diet pills market along with the drivers and restraints pertaining to the market growth. Increase in self-directed care and rising problem of obesity are the major factor driving the growth of the North America diet pills market. However, challenging regulatory environment hinders the growth of North America diet pills market.
The North America diet pills market is segmented based on product type, application, age group, distribution channel and country. Based on product type, the North America diet pills market is segmented into prescription, herbal supplements, and over the counter drugs. The prescription segment dominated the North America diet pills market in 2020. Based on application, the North America diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. The appetite suppression segment dominated the North America diet pills market in 2020. Based on age group, North America diet pills market is segmented into adults, and teenagers. The adults segment dominated the North America diet pills market in 2020. Based on distribution channel, North America diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug Stores. The hospital pharmacies segment dominated the North America diet pills market in 2020. Based on country, the North America diet pills market is segmented into US, Canada, and Mexico. The US segment dominated the North America diet pills market in 2020.
Pfizer Inc. (Arena Pharmaceutical GMBH); Novo Nordisk A/S; Gelesis; VIVUS LLC; GlaxoSmithKline plc; Lovate Health Sciences International Inc.; TEVA Pharmaceutical Industries LTD; Currax Pharmaceutical LLC; Chong’s Health Care; and Zoller Laboratories are among the leading companies in the North America Diet Pills market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2019, Gelesis received FDA Clearance to market PLENITY as an aid to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract. PLENITY represents a new prescription option for millions of adults.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com